Class information for:
Level 1: SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN

Basic class information
Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
7 4 CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL 1572904
202 3       DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES 52563
628 2             SGLT2 INHIBITOR//METFORMIN//DPP 4 INHIBITOR 14172
7314 1                   SGLT2 INHIBITOR//DAPAGLIFLOZIN//CANAGLIFLOZIN 1407

Terms with highest relevance score


rank Category termType chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 SGLT2 INHIBITOR authKW 5926059 22% 87% 303
2 DAPAGLIFLOZIN authKW 3498956 12% 92% 170
3 CANAGLIFLOZIN authKW 3234305 11% 95% 152
4 EMPAGLIFLOZIN authKW 2487865 9% 91% 122
5 SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR authKW 1947705 7% 84% 103
6 SGLT2 authKW 1864221 7% 82% 102
7 SODIUM GLUCOSE COTRANSPORTER 2 authKW 955652 3% 89% 48
8 IPRAGLIFLOZIN authKW 786235 3% 95% 37
9 SODIUM GLUCOSE CO TRANSPORTER 2 SGLT2 INHIBITOR authKW 671950 2% 100% 30
10 URINARY GLUCOSE EXCRETION authKW 633077 2% 91% 31

Web of Science journal categories


chi_square_rank Category chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 Endocrinology & Metabolism 9715 32% 0% 454
2 Pharmacology & Pharmacy 2591 26% 0% 372
3 Medicine, General & Internal 672 12% 0% 162
4 Chemistry, Medicinal 631 7% 0% 98
5 Urology & Nephrology 475 6% 0% 85
6 Medicine, Research & Experimental 216 6% 0% 82
7 Cardiac & Cardiovascular System 108 5% 0% 67
8 Toxicology 96 3% 0% 46
9 Chemistry, Organic 92 5% 0% 75
10 Physiology 81 4% 0% 51

Address terms


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 TIANJIN MOL DESIGN DRUG DISCOVERY 85118 1% 18% 21
2 PROD PLANNING COORDINAT 79991 0% 71% 5
3 DIABET DISCOVERY BIOL 67195 0% 100% 3
4 GLOBAL MED AFFAIRS DIABET METAB 44797 0% 100% 2
5 IKUYAKU MED 44797 0% 100% 2
6 INVEST CLIN SAN AGUSTIN 44797 0% 100% 2
7 MED AFFAIRS DEUT LAND 44797 0% 100% 2
8 METAB DIS DISCOVERY BIOL 44797 0% 100% 2
9 NEUROSCI PSYCHOL DRUG SCI CHILD HLTH 44797 0% 100% 2
10 NUCLEO AVANCADO NEFROL 44797 0% 100% 2

Journals


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass
1 DIABETES OBESITY & METABOLISM 99690 7% 4% 102
2 DIABETES THERAPY 55951 2% 10% 25
3 JOURNAL OF DIABETES INVESTIGATION 11095 1% 3% 18
4 CARDIOVASCULAR DIABETOLOGY 9705 2% 2% 24
5 LANCET DIABETES & ENDOCRINOLOGY 6071 1% 3% 9
6 CLINICAL THERAPEUTICS 5367 2% 1% 35
7 DIABETES CARE 4598 3% 0% 49
8 DIABETES & VASCULAR DISEASE RESEARCH 4115 1% 2% 9
9 CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT 3810 0% 2% 7
10 POSTGRADUATE MEDICINE 3802 2% 1% 30

Author Key Words


chi_square_rank term chi_square shrOfCwithTerm shrOfTermInClass termInClass LCSH search Wikipedia search
1 SGLT2 INHIBITOR 5926059 22% 87% 303 Search SGLT2+INHIBITOR Search SGLT2+INHIBITOR
2 DAPAGLIFLOZIN 3498956 12% 92% 170 Search DAPAGLIFLOZIN Search DAPAGLIFLOZIN
3 CANAGLIFLOZIN 3234305 11% 95% 152 Search CANAGLIFLOZIN Search CANAGLIFLOZIN
4 EMPAGLIFLOZIN 2487865 9% 91% 122 Search EMPAGLIFLOZIN Search EMPAGLIFLOZIN
5 SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR 1947705 7% 84% 103 Search SODIUM+GLUCOSE+COTRANSPORTER+2+INHIBITOR Search SODIUM+GLUCOSE+COTRANSPORTER+2+INHIBITOR
6 SGLT2 1864221 7% 82% 102 Search SGLT2 Search SGLT2
7 SODIUM GLUCOSE COTRANSPORTER 2 955652 3% 89% 48 Search SODIUM+GLUCOSE+COTRANSPORTER+2 Search SODIUM+GLUCOSE+COTRANSPORTER+2
8 IPRAGLIFLOZIN 786235 3% 95% 37 Search IPRAGLIFLOZIN Search IPRAGLIFLOZIN
9 SODIUM GLUCOSE CO TRANSPORTER 2 SGLT2 INHIBITOR 671950 2% 100% 30 Search SODIUM+GLUCOSE+CO+TRANSPORTER+2+SGLT2+INHIBITOR Search SODIUM+GLUCOSE+CO+TRANSPORTER+2+SGLT2+INHIBITOR
10 URINARY GLUCOSE EXCRETION 633077 2% 91% 31 Search URINARY+GLUCOSE+EXCRETION Search URINARY+GLUCOSE+EXCRETION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.

Classes with closest relation at Level 1


rank cluster_id2 link
1 38640 FANCONI BICKEL SYNDROME//GLYCOGEN STORAGE DISEASE TYPE XI//FANCONI BICKEL
2 10425 SGLT1//EPITHELIAL CELL PHYSIOL//SODIUM D GLUCOSE COTRANSPORTER
3 320 DPP 4 INHIBITOR//EXENATIDE//LIRAGLUTIDE
4 10710 IBMED//MED ABT RHEUMATOL STOFFWECHSELERKRANKUNGEN REHA//VADT
5 20787 ASYMPTOMATIC BACTERIURIA//DANISH STRATEG TYPE DIABET 2//99M TECHNETIUM DIMERCAPTO SUCCINIC ACID
6 16596 GLUT1//GLUCOSE TRANSPORTER 1//GLUT12
7 13029 NON DIABETIC RENAL DISEASE//DIABETIC GLOMERULOPATHY//DIABETIC NEPHROPATHY
8 22721 GLICLAZIDE//ARTIFICIAL CELL MICROENCAPSULATION//BIOTECHNOL DRUG DEV
9 36688 ACUTE RENAL FAILURE CLINICAL//ALPORT LIKE GLOMERULAR BASEMENT MEMBRANE CHANGES//ANAT RENAL PATHOL
10 1098 INSULIN GLARGINE//INSULIN ANALOGUES//INSULIN DETEMIR

Go to start page